medigraphic.com

2017, Number S1

<< Back

Rev Med Inst Mex Seguro Soc 2017; 55 (S1)

Correlation of heart rate variability with SYNTAX II on chronic angina

Castro-de la Torre TC, Amador-Licona N, Bernal-Ruíz E

Language: Spanish
References: 23
Page: 107-111
PDF size: 274.28 Kb.


ABSTRACT

Background: The heart rate variability (HRV) is a prognostic value of cardiovascular risk. It is unknown the correlation between HRV and coronary severity on patients with chronic angina. The objective was to determine the correlation between HRV and the SYNTAX II score in chronic angina.
Methods: Cross-sectional study in patients of 18 years or older with stable angina and indication of coronary angiography who went to a third level center. The SYNTAX II score was established by using coronary angiography, while HRV was obtained by a 24-hour Holter ECG. The correlation between SYNTAX II and HRV was performed with Pearson’s test. Values of SDNN ‹ 100 ms and RMSSD ‹ 15 ms were considered risk factors.
Results: 61 patients were included. 45 had a decreased value of SDNN (73.77%) and eight had a decreased value of RMSSD (13.11%). There was no correlation between HRV and SYNTAX II score. There were more events of ventricular tachycardia in the group of patients with low SDNN than in those with normal SDNN (15.5% vs. 0.0%; p = 0.04).
Conclusions: There was no correlation between HRV and the severity of coronary artery disease in stable chronic ischemic heart disease. However, those patients with low HRV showed more events of ventricular tachycardia.


REFERENCES

  1. Borrás-Pérez FX. Diagnostico y estratificación de la angina Estable. Rev Esp Cardiol Supl. 2012;12(D):9-14.

  2. Organización Mundial de la Salud (OMS). Informe mundial sobre prevención de los traumatismos causados por el tránsito. Ginebra, Suiza; 2004.

  3. Instituto Nacional de Estadística, Geografía e Informática. Epidemiología dela defunción poblacional. México: INEGI; 2007.

  4. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guía de Práctica clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del ST. Rev Esp Cardiol. 2007;60:1070 e1-80.

  5. Jeria C, Hernández R, Benn C. Alteración de la variabilidad del ritmo cardíaco en pacientes con síndrome coronario agudo sin supradesnivel del segmento ST. Experiencia preliminar. Rev Chil Cardiol. 2011;31(2):104-12.

  6. Heart rate variability. Standars of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996;17:354-81.

  7. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248:H151-3.

  8. Dixon EM, Kamath MV, McCartney N, Fallen EL. Neural regulation of heart rate variability in endurance athletes and sedentary controls. Cardiovasc Res. 1992 Jul;26(7):713-9.

  9. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005 Jan;10(1):88-101.

  10. Weber F, Schneider H, von Arnim T, Urbaszek W. Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. Eur Heart J. 1999 Jan;20(1):38-50.

  11. Konrady AO, Rudomanov OG, Yacovleva OI, Shlyakhto EV. Power spectral components of heart rate variability in different types of cardiac remodelling in hypertensive patients. Med Sci Monit. 2001 Jan-Feb;7(1):58-63.

  12. Scalvini S, Volterrani M, Zanelli E, Pagani M, Mazzuero G, Coats AJ, et al. Is heart rate variability a reliable method to assess autonomic modulation in left ventricular dysfunction and heart failure? Assessment of autonomic modulation with heart rate variability. Int J Cardiol. 1998 Nov 30;67(1):9-17.

  13. Stein PK, Domitrovich PP, Huikuri HV, Kleiger RE; Cast Investigators. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol. 2005 Jan;16(1):13-20.

  14. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987 Feb 1;59(4):256-62.

  15. Mølgaard H, Christensen PD, Hermansen K, Sørensen KE, Christensen CK, Mogensen CE. Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? Diabetologia. 1994 Aug;37(8):788-96.

  16. Odemuyiwa O, Poloniecki J, Malik M, Farrell T, Xia R, Staunton A, et al. Temporal influences on the prediction of postinfarction mortality by heart rate variability: a comparison with the left ventricular ejection fraction. Br Heart J. 1994 Jun;71(6):521-7.

  17. Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J. 2009 Mar;30(6):689-98.

  18. Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A, et al. Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISARRisk). Eur Heart J. 2009 Mar;30(5):576-83.

  19. Olenchock BA, Fonarow GG, Pan W, Hernandez A, Cannon CP. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. Am J Cardiol. 2009 Feb 1;103(3):295-300.

  20. Casolo GC, Stroder P, Signorini C, Calzolari F, Zucchini M, Balli E, et al. Heart rate variability during the acute phase of myocardial infarction. Circulation. 1992 Jun;85(6):2073-9.

  21. Feng J, Wang A, Gao C, Zhang J, Chen Z, Hou L, et al. Altered heart rate variability depend on the characteristics of coronary lesions in stable angina pectoris. Anatol J Cardiol. 2015 Jun;15(6):496-501.

  22. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006 Jun;151(6):1194-204.

  23. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013 Feb 23;381(9867):639-50.




2020     |     www.medigraphic.com